(Q38191147)

30 August 2017

Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature (English)

1 reference

30 August 2017

1 reference

Berman MA

1

1 reference

30 August 2017

Burnham JA

series ordinal

2

1 reference

30 August 2017

Sheahan DG

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

30 August 2017

1 reference

30 August 2017

19

1 reference

30 August 2017

7

1 reference

30 August 2017

784-794

1 reference

Hepatocellular carcinoma diagnostic and prognostic features in north american patients

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Primary hepatocellular carcinoma. Present state of the disease and prospects for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Histologic prognostic indicators in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Primary liver cancer: A review of 205 cases in Hawaii

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

The natural history of primary carcinoma of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

A clinicopathological review of 100 cases of primary malignant tumours of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Primary malignant tumors of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

1 reference

7 January 2021

Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

The variable course of primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Fibrolamellar hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Ground-glass Cells in Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Neurotensin secretion by fibrolamellar carcinoma of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Copper and copper-binding protein in fibrolamellar liver cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatocellular carcinoma in young people

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Fibrolamellar Carcinoma of the Liver: The Malignant Counterpart of Focal Nodular Hyperplasia with Oncocytic Change

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Case report. Hepatocellular carcinoma with lamellar fibrosis: An important histological variant

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Oncocytic hepatocellular tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hyaline Globules and Intracellular Lumina in a Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Fibrolamellar hepatocarcinoma: radiology, management, and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Ultrastructure of fibrolamellar oncocytic hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Clinicopathologic features of encapsulated hepatocellular carcinoma.A study of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatic Oncocytes: Incidence, Staining Characteristics, and Ultrastructural Features

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Oxyphilic granular hepatocytes. Mitochondrion-rich liver cells in hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Intracytoplasmic hyaline globules in hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hyaline globules of the adrenal medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Expression of protein markers in malignant hepatoma. Evidence for genetic and epigenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Demonstration of alpha1-antitrypsin in paraffin sections of hepatoma and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Alpha-1-antitrypsin globules in the liver and PiM phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Alpha-1-antitrypsin deficiency and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

α-1-antitrypsin phenotypes in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Changes in serum alpha1 antitrypsin, alpha1 acid glycoprotein and beta2 glycoprotein i in patients with malignant hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Serum alpha-feto-protein and primary cancer of the liver in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatitis-b antigen and cirrhosis in bantu patients with primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Serum alpha-fetoglobulin and primary cancer of the liver in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Alpha1-fetoprotein in the diagnosis of hepatoma: statistical and cost benefit aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Demonstration of alpha-Fetoglobulin in hepatoma tissue by fluorescent antibody technique

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Immunofluorescent study of alpha-foetoprotein (alpha-fp) in liver and liver liver tumours. I. Technique of alpha-fp localization in tissue sections.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Immunofluorescent study of alpha-foetoprotein (αfp) in liver and liver tumours. II. Localization of αfp in the tissues of patients with primary liver cancer (PLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Immunofluorescent localisation of human alpha feto-protein in fetal and neonatal livers and cultured cells from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Carcino-foetal human liver ferritins

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Isolation and characterization of a novel vitamin B12-binding protein associated with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatitis B Virus and the Prevention of Primary Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

The Changing Incidence of Association of Hepatitis B with Hepatocellular Carcinoma in California

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Cytoplasmic Hepatitis B Surface Antigen and the Ground-glass Appearance in Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatitis B surface antigen and hepatocellular carcinoma in the people's Republic of China

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Cellular Localization of Hepatitis B Virus Antigens in Patients with Hepatocellular Carcinoma Coexisting with Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

A case/control study of the association between primary liver cancer and hepatitis b infection in senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Primary liver cell carcinoma in the presence or absence of hepatitis b antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Integration of hepatitis B virus sequences and their expression in a human hepatoma cell

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Endocrine liver tumour differential diagnosis from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

The histopathologic and clinical indicators of prognosis in hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

A Rare Case of Megaloblastic Anaemia Caused by Disturbances in the Plasma Cobalamin Binding Proteins in a Patient with Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

Hepatitis B surface antigen and liver cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2888%2980261-2

7 January 2021

10.1016/S0046-8177(88)80261-2

Identifiers

DOI

1 reference

30 August 2017

1 reference